ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment
Open Access
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 18 (10) , 2331-2342
Abstract
No abstract availableKeywords
Funding Information
- Ford Foundation (P41EB015890)
- National Cancer Institute (1R01AR063116)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of Biomedical Imaging and Bioengineering (P30CA062203)
- National Institutes of Health (1R01CA151513-01)
- National Science Foundation (DGE-1321846)
This publication has 47 references indexed in Scilit:
- A Landscape of Driver Mutations in MelanomaCell, 2012
- A prognostic signature of defective p53‐dependent G1 checkpoint function in melanoma cell linesPigment Cell & Melanoma Research, 2012
- Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer SyndromeThe American Journal of Human Genetics, 2012
- Butyrophilins: an emerging family of immune regulatorsTrends in Immunology, 2012
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- Skint-1 is a highly specific, unique selecting component for epidermal T cellsProceedings of the National Academy of Sciences, 2011
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53Nature Genetics, 2009
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- ATR: an essential regulator of genome integrityNature Reviews Molecular Cell Biology, 2008
- Deletion of the Developmentally Essential Gene ATR in Adult Mice Leads to Age-Related Phenotypes and Stem Cell LossCell Stem Cell, 2007